Effect of Bevacizumab on Asymptomatic Radiotherapy-induced Brain Injury

Clinical Study of Radiotherapy Combined With Nedaplatin Contrast and Cisplatin for the Treatment of Locally Advanced Head and Neck Squamous Carcinoma

NCT05039606 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer

NCT00023959 ·Status: COMPLETED ·Phase: PHASE1

Concurrent Chemoradiotherapy for Cervical Cancer in Elderly Women

NCT01594099 ·Status: UNKNOWN ·Phase: PHASE2

The Effect of COX-2 Inhibitor on Radiosensitivity in Nasopharyngeal Carcinoma

NCT02537925 ·Status: UNKNOWN ·Phase: PHASE3

A Prospective Study of Monitoring Immune Response in Locally Advanced Cervix Cancer

NCT03559803 ·Status: UNKNOWN ·Phase: NA

A Study of SHR-1701 Plus Platinum-containing Chemotherapy With or Without BP102 (Bevacizumab) as First-line Treatment in Cervical Cancer

NCT05179239 ·Status: TERMINATED ·Phase: PHASE3

Definitive Chemo-Radiotherapy for Regionally Advanced Head and Neck Cancer With or Without Up-front Neck Dissection

NCT02918955 ·Status: COMPLETED ·Phase: PHASE3

Angiogenic and EGFR Blockade With Curative Chemoradiation for Advanced Head and Neck Cancer

NCT00140556 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Long-term Neurovascular Complications After Radiation Therapy in Head and Neck Cancer

NCT06111430 ·Status: RECRUITING

Pelvic RT Versus Prophylactic Extended-field RT in Patients With Cervical Cancer

NCT03955367 ·Status: UNKNOWN ·Phase: PHASE3

Bevacizumab, Docetaxel, and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer

NCT00281840 ·Status: COMPLETED ·Phase: PHASE2

A Phase II Study of Serplulimab Plus Bevacizumab in Combination With Chemotherapy in 1L Treatment of Untreated Recurrent or Metastatic Cervical Cancer

NCT05444374 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Neoadjuvant Chemotherapy and Radical Surgery in Stage IIB Cervical Cancer

NCT02595554 ·Status: UNKNOWN ·Phase: PHASE3

Chemo-Radiotherapy Boost Treatment Guided by Perfusion MRI on Hypoxic Zones in Head and Neck Cancer

NCT06880289 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Treatment of Head & Neck Cancer With Chemotherapy and Radiation

NCT00392704 ·Status: COMPLETED ·Phase: PHASE2

Bioimmunoradiotherapy (Cetuximab/RT/Avelumab)

NCT02938273 ·Status: COMPLETED ·Phase: PHASE1

Bevacizumab, Radiation Therapy, and Cisplatin in Treating Patients With Previously Untreated Locally Advanced Cervical Cancer

NCT00369122 ·Status: COMPLETED ·Phase: PHASE2

Study Comparing RT With Cetuximab + Xevinapant to RT With Cetuximab-placebo in Patients With Head and Neck Cancer

NCT05930938 ·Status: TERMINATED ·Phase: PHASE3

Stereotactic Radiosurgery in Treating Patients With Locally Advanced or Recurrent Head and Neck Cancer

NCT00851253 ·Status: COMPLETED ·Phase: NA

Sunitinib, Cetuximab, and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck

NCT00906360 ·Status: TERMINATED ·Phase: PHASE1

Chemotherapy, Radiation Therapy, and Cetuximab in Treating Patients With the Head and Neck Cancer

NCT00875849 ·Status: COMPLETED ·Phase: PHASE2

Stereotactic Body Radiation Therapy in Treating Patients With High Risk Locally Advanced Head and Neck Cancer

NCT02388932 ·Status: TERMINATED ·Phase: NA

Bevacizumab, Cetuximab, and Cisplatin With IMRT (Intensity-Modulated Radiation Therapy) for Patients With Stage III/IV Head and Neck Squamous Cell Carcinoma

NCT00968435 ·Status: COMPLETED ·Phase: PHASE2

Concurrent Chemoradiotherapy(CRT) in Locally Advanced(LA) SCCHN vs Cetuximab With Radiotherapy (RT) After Neoadjuvant Chemotherapy

NCT02753140 ·Status: UNKNOWN ·Phase: PHASE2

Radiation Therapy and Cetuximab in Treating Patients With Recurrent Head and Neck Cancer

NCT00891904 ·Status: TERMINATED ·Phase: NA